156 related articles for article (PubMed ID: 12215063)
1. Dexmethylphenidate.
Keating GM; Figgitt DP
Drugs; 2002; 62(13):1899-904; discussion 1905-8. PubMed ID: 12215063
[TBL] [Abstract][Full Text] [Related]
2. Dexmethylphenidate extended release: in attention-deficit hyperactivity disorder.
Robinson DM; Keating GM
Drugs; 2006; 66(5):661-8; discussion 669-70. PubMed ID: 16620143
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, placebo-controlled withdrawal trial of dexmethylphenidate hydrochloride in children with attention deficit hyperactivity disorder.
Arnold LE; Lindsay RL; Conners CK; Wigal SB; Levine AJ; Johnson DE; West SA; Sangal RB; Bohan TP; Zeldis JB
J Child Adolesc Psychopharmacol; 2004; 14(4):542-54. PubMed ID: 15662146
[TBL] [Abstract][Full Text] [Related]
4. A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder.
Wigal S; Swanson JM; Feifel D; Sangal RB; Elia J; Casat CD; Zeldis JB; Conners CK
J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1406-14. PubMed ID: 15502600
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, crossover study of once-daily dexmethylphenidate in children with attention-deficit hyperactivity disorder: rapid onset of effect.
Brams M; Muniz R; Childress A; Giblin J; Mao A; Turnbow J; Borrello M; McCague K; Lopez FA; Silva R
CNS Drugs; 2008; 22(8):693-704. PubMed ID: 18601306
[TBL] [Abstract][Full Text] [Related]
6. Dexmethylphenidate--Novartis/Celgene. Focalin, D-MPH, D-methylphenidate hydrochloride, D-methylphenidate, dexmethylphenidate, dexmethylphenidate hydrochloride.
Drugs R D; 2002; 3(4):279-82. PubMed ID: 12455205
[TBL] [Abstract][Full Text] [Related]
7. Does chirality matter? pharmacodynamics of enantiomers of methylphenidate in patients with attention-deficit/hyperactivity disorder.
Quinn D
J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S62-6. PubMed ID: 18480679
[TBL] [Abstract][Full Text] [Related]
8. Dexmethylphenidate extended release: a review of its use in the treatment of attention-deficit hyperactivity disorder.
Moen MD; Keam SJ
CNS Drugs; 2009 Dec; 23(12):1057-83. PubMed ID: 19958043
[TBL] [Abstract][Full Text] [Related]
9. Open-label study of dexmethylphenidate hydrochloride in children and adolescents with attention deficit hyperactivity disorder.
Silva R; Tilker HA; Cecil JT; Kowalik S; Khetani V; Faleck H; Patin J
J Child Adolesc Psychopharmacol; 2004; 14(4):555-63. PubMed ID: 15662147
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of extended-release dexmethylphenidate compared with d,l-methylphenidate and placebo in the treatment of children with attention-deficit/hyperactivity disorder: a 12-hour laboratory classroom study.
Muniz R; Brams M; Mao A; McCague K; Pestreich L; Silva R
J Child Adolesc Psychopharmacol; 2008 Jun; 18(3):248-56. PubMed ID: 18582179
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and duration of effect of extended-release dexmethylphenidate versus placebo in schoolchildren with attention-deficit/hyperactivity disorder.
Silva RR; Muniz R; Pestreich L; Childress A; Brams M; Lopez FA; Wang J
J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):239-51. PubMed ID: 16768632
[TBL] [Abstract][Full Text] [Related]
12. Methylphenidate and dexmethylphenidate formulations for children with attention-deficit/hyperactivity disorder.
Sugrue D; Bogner R; Ehret MJ
Am J Health Syst Pharm; 2014 Jul; 71(14):1163-70. PubMed ID: 24973373
[TBL] [Abstract][Full Text] [Related]
13. An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder.
Shang CY; Pan YL; Lin HY; Huang LW; Gau SS
J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):566-73. PubMed ID: 26222447
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of dexmethylphenidate extended-release capsules in children with attention-deficit/hyperactivity disorder.
Greenhill LL; Muniz R; Ball RR; Levine A; Pestreich L; Jiang H
J Am Acad Child Adolesc Psychiatry; 2006 Jul; 45(7):817-23. PubMed ID: 16832318
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of dexmethylphenidate extended-release capsules administered once daily to children with attention-deficit/hyperactivity disorder.
Childress AC; Spencer T; Lopez F; Gerstner O; Thulasiraman A; Muniz R; Post A
J Child Adolesc Psychopharmacol; 2009 Aug; 19(4):351-61. PubMed ID: 19702487
[TBL] [Abstract][Full Text] [Related]
16. Extended-release methylphenidate (Ritalin LA).
Lyseng-Williamson KA; Keating GM
Drugs; 2002; 62(15):2251-9; discussion 2260-1. PubMed ID: 12381228
[TBL] [Abstract][Full Text] [Related]
17. Effect of vitamin D supplementation as adjunctive therapy to methylphenidate on ADHD symptoms: A randomized, double blind, placebo-controlled trial.
Mohammadpour N; Jazayeri S; Tehrani-Doost M; Djalali M; Hosseini M; Effatpanah M; Davari-Ashtiani R; Karami E
Nutr Neurosci; 2018 Apr; 21(3):202-209. PubMed ID: 27924679
[TBL] [Abstract][Full Text] [Related]
18. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
[TBL] [Abstract][Full Text] [Related]
19. Amantadine versus methylphenidate in children and adolescents with attention deficit/hyperactivity disorder: a randomized, double-blind trial.
Mohammadi MR; Kazemi MR; Zia E; Rezazadeh SA; Tabrizi M; Akhondzadeh S
Hum Psychopharmacol; 2010 Nov; 25(7-8):560-5. PubMed ID: 21312290
[TBL] [Abstract][Full Text] [Related]
20. Methylphenidate (OROS formulation).
Keating GM; McClellan K; Jarvis B
CNS Drugs; 2001; 15(6):495-500; discussion 501-3. PubMed ID: 11524026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
